R

RAPT Therapeutics
D

RAPT

7.37000
USD
0.00
(0.00%)
مغلق
حجم التداول
4,478
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
121,870,946
أصول ذات صلة
ABBV
ABBV
-0.290
(-0.16%)
185.210 USD
AMGN
AMGN
-0.10
(-0.03%)
289.40 USD
BIIB
BIIB
0.480
(0.38%)
127.050 USD
BMY
BMY
0.005
(0.01%)
46.860 USD
GILD
GILD
-0.020
(-0.02%)
108.000 USD
JNJ
JNJ
-0.970
(-0.64%)
149.760 USD
MRK
MRK
-0.180
(-0.23%)
79.110 USD
PFE
PFE
0.085
(0.36%)
23.970 USD
REGN
REGN
-3.73
(-0.73%)
509.70 USD
المزيد
الأخبار المقالات

العنوان: RAPT Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cellsinto inflamed tissues.